Introduction
The 4Ts score is a bedside clinical prediction tool used to estimate the probability that a patient's falling platelet count is caused by heparin-induced thrombocytopenia (HIT), rather than one of the many other, more common reasons platelets drop in hospitalized patients. HIT is an immune-mediated reaction in which antibodies against platelet factor 4 (PF4) bound to heparin activate platelets, paradoxically causing both a low platelet count and a high risk of new blood clots.
The 4Ts score works by scoring four clinical features, each contributing 0 to 2 points, for a maximum of 8: the magnitude of the platelet fall, the timing of that fall relative to heparin exposure, the presence of thrombosis or other complications, and whether other causes of thrombocytopenia are present.
It was developed by Lo and colleagues in 2006 and has since become the standard first step in HIT evaluation worldwide [1]. It is used mainly by hematologists, intensivists, and internal medicine physicians managing patients on heparin or low-molecular-weight heparin, particularly in ICU, post-surgical, and cardiology settings where heparin exposure is common.
The 4Ts Score Criteria
| Criterion | 0 Points | 1 Point | 2 Points |
|---|---|---|---|
| Thrombocytopenia (magnitude) | Platelet fall < 30%, or nadir < 10 × 10⁹/L | Platelet fall 30–50%, or nadir 10–19 × 10⁹/L | Platelet fall > 50% and nadir ≥ 20 × 10⁹/L |
| Timing of platelet fall | Fall < 4 days without recent heparin exposure | Fall consistent but unclear (e.g., missing counts), fall after day 10, or fall ≤ 1 day with prior heparin exposure 31–100 days ago [3] | Fall on days 5–10 after starting heparin, or ≤ 1 day if heparin was given in the past 30 days |
| Thrombosis or other sequelae | None | Progressive, recurrent, or suspected thrombosis | Confirmed new thrombosis, skin necrosis at injection sites, or an acute systemic reaction after IV heparin |
| Other causes for thrombocytopenia | A definite other cause is present | A possible other cause is present | No other apparent cause |
The timing domain deserves special attention. Day 0 is the first day of heparin exposure. The typical HIT pattern is a platelet fall starting 5 to 10 days after heparin begins, since it takes time for anti-PF4/heparin antibodies to form. An abrupt fall within a day of starting heparin can still score highly, but only if the patient received heparin within the previous 30 days, since pre-formed antibodies can trigger a rapid reaction on re-exposure.
The 4Ts Score Calculator
4Ts Score Calculator for HIT
Interpreting the 4Ts Score
The total score sorts patients into three pretest probability categories, each with a different downstream approach [1,2]:
Low probability (score 0–3): < 1% risk of HIT.
HIT is effectively ruled out, as a low-probability score has a negative predictive value or 99.8% [3].
Intermediate probability (score 4–5): ~14% risk of HIT.
HIT is possible. Heparin products should be stopped and replaced with a non-heparin anticoagulant while a HIT antibody immunoassay (anti-PF4/heparin ELISA) is sent. For clinically stable patients, direct oral anticoagulants (DOACs) such as rivaroxaban or apixaban, or fondaparinux are currently preferred. Intravenous agents like argatroban or bivalirudin are typically reserved for critically ill patients [2].
High probability (score 6–8): ~64% risk of HIT.
HIT is likely. Heparin is stopped immediately, a non-heparin anticoagulant is started empirically without waiting for lab results, and confirmatory antibody and functional testing is sent.
A key strength of the tool is its negative predictive value: a low 4Ts score reliably rules out HIT, which avoids unnecessary and costly changes in anticoagulation. A high score, on the other hand, does not confirm HIT on its own. It only justifies starting empirical treatment and pursuing laboratory confirmation.
Case Scenarios
Scenario 1: Low probability, HIT safely excluded
A 72-year-old man on prophylactic LMWH after hip surgery has a platelet count that falls from 220 to 180 × 10⁹/L (a 18% fall) over the first week. He has active sepsis from a urinary tract infection.
Calculator Exercise: What is his total score?
Clinical Interpretation: His points are thrombocytopenia magnitude (0, fall < 30%), timing (1, fall pattern unclear given overlapping illness), thrombosis (0, none), other causes (0, sepsis is a definite alternative cause) = 4Ts score = 1 → low probability. HIT antibody testing is not ordered, and LMWH is continued while the infection is treated.
Scenario 2: Intermediate probability, testing and empirical switch
A 58-year-old woman on unfractionated heparin after a myocardial infarction has a platelet count fall from 250 to 95 × 10⁹/L (a 62% fall) on day 6 of heparin. She has no new thrombosis and no other clear cause of thrombocytopenia identified.
Calculator Exercise: What is her total score?
Clinical Interpretation: Her points are thrombocytopenia (2, fall > 50% and nadir ≥ 20), timing (2, fall on day 6), thrombosis (0, none), other causes (1, no clear alternative but not fully excluded) = 4Ts score = 5 → intermediate probability. Heparin is stopped, a non-heparin anticoagulant is started, and a HIT antibody test is sent.
Scenario 3: High probability, treat before confirmation
A 65-year-old man on therapeutic LMWH develops a platelet count fall from 300 to 60 × 10⁹/L (an 80% fall) on day 8, together with a new deep vein thrombosis in the opposite leg from where his central line sits. No infection, medication reaction, or other explanation is found.
Calculator Exercise: What is his total score?
Clinical Interpretation: His points are thrombocytopenia (2, fall > 50% and nadir ≥ 20), timing (2, day 8 fits the classic window), thrombosis (2, confirmed new DVT), other causes (2, no other cause apparent) = 4Ts score = 8 → high probability. All heparin products are stopped immediately, a non-heparin anticoagulant (e.g., argatroban) is started that day, and confirmatory antibody and functional testing follow.
Limitations of the 4Ts Score
The 4Ts score depends on accurate, complete platelet count trends and a clear heparin exposure history, both of which can be incomplete in complex ICU patients. Inter-observer agreement on individual domains, particularly "other causes," has been shown to vary between clinicians [3]. In critically ill patients, where thrombocytopenia is common for many reasons, a low score still reliably excludes HIT, but scoring can be more difficult to apply consistently than in general ward patients. Some centers use the 4Ts score alongside the HIT Expert Probability (HEP) score for additional support before committing to expensive antibody testing.
Disclaimer: This article is intended for educational and informational purposes only. It is not intended to be a substitute for informed professional medical advice, diagnosis, or treatment. While the information presented here is derived from credible medical sources and is believed to be accurate and up-to-date, it is not guaranteed to be complete or error-free. See additional information.
References
- Lo, G. K., Juhl, D., Warkentin, T. E., Sigouin, C. S., Eichler, P., & Greinacher, A. (2006). Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. Journal of thrombosis and haemostasis : JTH, 4(4), 759–765. https://doi.org/10.1111/j.1538-7836.2006.01787.x
- Cuker, A., Arepally, G. M., Chong, B. H., Cines, D. B., Greinacher, A., Gruel, Y., Linkins, L. A., Rodner, S. B., Selleng, S., Warkentin, T. E., Wex, A., Mustafa, R. A., Morgan, R. L., & Santesso, N. (2018). American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood advances, 2(22), 3360–3392. https://doi.org/10.1182/bloodadvances.2018024489
- Cuker, A., Gimotty, P. A., Crowther, M. A., & Warkentin, T. E. (2012). Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood, 120(20), 4160–4167. https://doi.org/10.1182/blood-2012-07-443051
